School of Medicine
Showing 781-790 of 1,304 Results
Thomas Charles Merigan M.D.
George E. and Lucy Becker Professor of Medicine, Emeritus
Current Research and Scholarly Interests I am now emeritus and only participate in university activities through advising my former trainees who have joined the faculty.
Everett Meyer, M.D., Ph.D.
Assistant Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Current Research and Scholarly Interests Research focus in T cell immunotherapy and T cell immune monitoring using high-throughput sequencing and genomic approaches, with an emphasis on hematopoietic stem cell transplantation, the treatment of graft-versus-host disease and immune tolerance induction.
Stanford University Professor of Nephrology
Current Research and Scholarly Interests Inadequate removal of uremic solutes contributes to widespread illness in the more than 350,000 Americans maintained on hemodialysis. But we know remarkably little about these solutes. Dr. Meyer's research efforts are focused on identifying which uremic solutes are toxic, how these solutes are made, and how their production could be decreased or their removal could be increased. We should be able to improve treatment if we knew more about what we are trying to remove.
David Miklos, M.D., Ph.D.
Associate Professor of Medicine (Blood and Marrow Transplantation) at the Stanford University Medical Center
Current Research and Scholarly Interests Investigates the targets of immune responses after human allogeneic stem cell transplantation. BMT patients develop antibodies against minor histocompatibility antigens (mHA) that are associated with chronic graft-v-host disease (cGVHD) and disease remission. Current projects: investigate Ab anti-tumor mechanism, high-throughput serologic identification of novel mHA in the development of GVHD and prevention of disease relapse, and clinical trials of B cell therapeutics for cGVHD.
Clint L. Miller
Instructor, Medicine - Cardiovascular Medicine
Bio My research focus involves the application of modern genomics to unravel complex human diseases and promote health. By integrating large-scale human genetic association data with multi-omic profiling and functional models, my work seeks to better understand causal disease mechanisms. Recent efforts involve the discovery of regulatory variants associated with coronary artery disease (CAD) linked to changes in chromatin structure and gene expression in primary vascular cells and tissues. This work encompasses genomics, epigenomics, transcriptomics and the development and application of robust and integrative computational pipelines. We are currently mapping differential allele-specific chromatin states and gene expression in large cohorts using various statistical frameworks. Ultimately these approaches will shed light on the functions and interactions of common regulatory variants, as well as hierarchical patterns of transcription factor binding, chromatin accessibility, and nucleosome positions in different environments. We are applying site-specific genomic targeting in inducible pluripotent stem cells (iPSC) and animal models to further close the gap between associations and disease-relevant phenotypes. I currently maintain a unique biobank of vascular tissues from explanted donor hearts. I am also involved with developing specialized curricula in genomic medicine for both medical students and practicing physicians.
Professor of Medicine (General Medical Discipline)
Current Research and Scholarly Interests Design and national demonstration of innovations in care delivery that provide more with less. Informed by research on AI-assisted clinical workflow, positive value outlier analysis and triggers of loss aversion bias among patients and clinicians.
Research on creation of a national index of health system productivity gain.